Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 3.0 |
| Revenue growth | -100.0% | |
| Cost of goods sold | 0.0 | 0.4 |
| Gross profit | 0.0 | 2.6 |
| Gross margin | | 86.4% |
| Research and development | 9.3 | 16.6 |
| General and administrative | 7.2 | 8.5 |
| EBIT | -16.5 | -45.6 |
| EBIT margin | | -1519.3% |
| Pre-tax income | -17.0 | -46.7 |
| Income taxes | 0.0 | 0.4 |
| Tax rate | 0.0% | |
| Net income | -17.0 | -47.1 |
| Net margin | | -1568.9% |
| |
| Diluted EPS | ($0.40) | ($1.45) |
| Shares outstanding (diluted) | 42.4 | 32.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|